Magnesium in PDB 4rao: Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Enzymatic activity of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
All present enzymatic activity of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents:
2.4.2.8;
Protein crystallography data
The structure of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents, PDB code: 4rao
was solved by
D.T.Keough,
D.Hockov,
Z.Janeba,
T-H.Wang,
L.Naesens,
M.D.Edstein,
M.Chavchich,
L.W.Guddat,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.41 /
1.87
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
76.602,
92.853,
114.849,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.1 /
23
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
(pdb code 4rao). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the
Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents, PDB code: 4rao:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Magnesium binding site 1 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 1 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg302
b:28.6
occ:1.00
|
O
|
A:HOH449
|
2.2
|
42.4
|
1.0
|
O
|
A:HOH450
|
2.3
|
40.6
|
1.0
|
O
|
A:HOH418
|
2.3
|
34.6
|
1.0
|
OE1
|
A:GLU133
|
2.3
|
40.9
|
1.0
|
OD1
|
A:ASP134
|
2.4
|
28.7
|
1.0
|
O
|
A:HOH426
|
2.4
|
42.2
|
1.0
|
CD
|
A:GLU133
|
2.7
|
42.2
|
1.0
|
OE2
|
A:GLU133
|
2.7
|
44.7
|
1.0
|
CG
|
A:ASP134
|
3.4
|
29.8
|
1.0
|
OD2
|
A:ASP134
|
3.7
|
38.0
|
1.0
|
CG
|
A:GLU133
|
3.9
|
40.5
|
1.0
|
CAP
|
A:3L7301
|
4.1
|
73.3
|
1.0
|
CG1
|
A:VAL66
|
4.3
|
32.1
|
1.0
|
N
|
A:ASP134
|
4.4
|
23.6
|
1.0
|
OAE
|
A:3L7301
|
4.4
|
61.3
|
1.0
|
O
|
A:ILE135
|
4.5
|
26.3
|
1.0
|
O
|
A:HOH411
|
4.6
|
40.2
|
1.0
|
CAJ
|
A:3L7301
|
4.6
|
59.9
|
1.0
|
N
|
A:ILE135
|
4.7
|
27.1
|
1.0
|
CB
|
A:ASP134
|
4.7
|
29.5
|
1.0
|
O
|
A:VAL66
|
4.7
|
25.0
|
1.0
|
NAY
|
A:3L7301
|
4.7
|
42.7
|
1.0
|
CB
|
A:VAL66
|
4.9
|
30.3
|
1.0
|
O
|
A:HOH444
|
4.9
|
48.8
|
1.0
|
CAK
|
A:3L7301
|
5.0
|
72.8
|
1.0
|
|
Magnesium binding site 2 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 2 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg303
b:45.8
occ:1.00
|
OD1
|
A:ASP193
|
2.3
|
37.5
|
1.0
|
OAD
|
A:3L7301
|
2.4
|
60.8
|
1.0
|
O
|
A:HOH451
|
2.6
|
49.4
|
1.0
|
O
|
A:HOH452
|
2.7
|
50.2
|
1.0
|
CG
|
A:ASP193
|
3.1
|
32.5
|
1.0
|
OD2
|
A:ASP193
|
3.2
|
35.7
|
1.0
|
CAK
|
A:3L7301
|
3.8
|
72.8
|
1.0
|
PBA
|
A:3L7301
|
3.9
|
66.7
|
1.0
|
O
|
A:HOH448
|
4.0
|
40.8
|
1.0
|
NH2
|
A:ARG199
|
4.1
|
32.2
|
1.0
|
CAP
|
A:3L7301
|
4.3
|
73.3
|
1.0
|
O
|
A:ASP193
|
4.4
|
36.1
|
1.0
|
CB
|
A:ASP193
|
4.5
|
31.0
|
1.0
|
OAE
|
A:3L7301
|
4.7
|
61.3
|
1.0
|
OAB
|
A:3L7301
|
4.8
|
58.2
|
1.0
|
C
|
A:ASP193
|
4.9
|
37.9
|
1.0
|
CZ
|
A:ARG199
|
4.9
|
30.2
|
1.0
|
NH1
|
A:ARG199
|
4.9
|
28.3
|
1.0
|
N
|
A:ASP193
|
5.0
|
27.9
|
1.0
|
|
Magnesium binding site 3 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 3 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg302
b:75.0
occ:1.00
|
OE1
|
B:GLU133
|
2.1
|
35.9
|
0.5
|
OD1
|
B:ASP134
|
2.1
|
31.8
|
1.0
|
OE1
|
B:GLU133
|
2.2
|
33.2
|
0.1
|
CAJ
|
B:3L7301
|
2.2
|
42.7
|
0.6
|
CD
|
B:GLU133
|
2.5
|
31.5
|
0.5
|
OAU
|
B:3L7301
|
2.6
|
42.7
|
0.6
|
CAL
|
B:3L7301
|
2.8
|
41.2
|
0.6
|
OE2
|
B:GLU133
|
2.8
|
35.0
|
0.5
|
CAK
|
B:3L7301
|
3.1
|
39.2
|
0.6
|
CG
|
B:ASP134
|
3.1
|
31.7
|
1.0
|
CD
|
B:GLU133
|
3.4
|
31.5
|
0.1
|
OD2
|
B:ASP134
|
3.5
|
41.4
|
1.0
|
CG
|
B:GLU133
|
3.6
|
28.9
|
0.5
|
OE2
|
B:GLU133
|
3.9
|
32.0
|
0.1
|
CAL
|
B:3L7301
|
4.0
|
40.9
|
0.3
|
N
|
B:ASP134
|
4.1
|
22.9
|
1.0
|
NAY
|
B:3L7301
|
4.2
|
40.2
|
0.3
|
O
|
B:ILE135
|
4.2
|
31.1
|
1.0
|
NAY
|
B:3L7301
|
4.3
|
40.5
|
0.6
|
CG1
|
B:VAL66
|
4.3
|
30.3
|
1.0
|
N
|
B:ILE135
|
4.3
|
27.2
|
1.0
|
CB
|
B:ASP134
|
4.4
|
30.8
|
1.0
|
OE1
|
B:GLU133
|
4.5
|
30.3
|
0.5
|
CG
|
B:GLU133
|
4.5
|
29.2
|
0.1
|
CAP
|
B:3L7301
|
4.6
|
35.5
|
0.6
|
CG
|
B:GLU133
|
4.6
|
29.9
|
0.5
|
OG1
|
B:THR141
|
4.6
|
39.8
|
0.3
|
CA
|
B:ASP134
|
4.7
|
23.0
|
1.0
|
CG2
|
B:THR141
|
4.7
|
39.9
|
0.7
|
CB
|
B:GLU133
|
4.7
|
27.3
|
0.5
|
CG2
|
B:ILE135
|
4.8
|
38.8
|
1.0
|
O
|
B:VAL66
|
4.8
|
24.4
|
1.0
|
CB
|
B:GLU133
|
4.8
|
27.5
|
0.5
|
CB
|
B:VAL66
|
4.8
|
31.6
|
1.0
|
CAN
|
B:3L7301
|
4.8
|
38.4
|
0.6
|
CB
|
B:GLU133
|
4.9
|
26.8
|
0.1
|
CA
|
B:GLU133
|
5.0
|
25.3
|
0.5
|
CA
|
B:GLU133
|
5.0
|
25.7
|
0.5
|
C
|
B:GLU133
|
5.0
|
24.9
|
0.5
|
CA
|
B:GLU133
|
5.0
|
25.8
|
0.1
|
|
Magnesium binding site 4 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 4 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg303
b:36.8
occ:1.00
|
O
|
B:HOH447
|
2.0
|
41.2
|
1.0
|
OD1
|
B:ASP193
|
2.2
|
29.8
|
1.0
|
O
|
B:HOH448
|
2.3
|
44.5
|
1.0
|
OAE
|
B:3L7301
|
2.3
|
27.3
|
0.6
|
O
|
B:HOH446
|
2.3
|
37.2
|
1.0
|
O
|
B:HOH421
|
2.5
|
37.7
|
1.0
|
CG
|
B:ASP193
|
3.0
|
30.6
|
1.0
|
OD2
|
B:ASP193
|
3.2
|
29.4
|
1.0
|
PBA
|
B:3L7301
|
3.6
|
32.0
|
0.6
|
OAB
|
B:3L7301
|
3.7
|
60.9
|
0.3
|
O
|
B:HOH414
|
4.1
|
48.2
|
1.0
|
CAP
|
B:3L7301
|
4.1
|
35.5
|
0.6
|
OAD
|
B:3L7301
|
4.1
|
31.2
|
0.6
|
NH2
|
B:ARG199
|
4.1
|
29.8
|
1.0
|
O
|
B:ASP193
|
4.2
|
25.6
|
1.0
|
O
|
B:HOH441
|
4.4
|
44.4
|
1.0
|
OAU
|
B:3L7301
|
4.4
|
43.1
|
0.3
|
CB
|
B:ASP193
|
4.4
|
24.1
|
1.0
|
CAJ
|
B:3L7301
|
4.5
|
40.1
|
0.3
|
O
|
B:HOH429
|
4.5
|
44.5
|
1.0
|
C
|
B:ASP193
|
4.7
|
25.7
|
1.0
|
N3
|
B:3L7301
|
4.7
|
33.9
|
0.6
|
N3
|
B:3L7301
|
4.8
|
33.9
|
0.3
|
OAB
|
B:3L7301
|
4.8
|
26.8
|
0.6
|
N
|
B:ASP193
|
4.8
|
26.7
|
1.0
|
NH1
|
B:ARG199
|
4.9
|
25.4
|
1.0
|
CAK
|
B:3L7301
|
4.9
|
42.9
|
0.3
|
CA
|
B:ASP193
|
4.9
|
22.4
|
1.0
|
CZ
|
B:ARG199
|
4.9
|
28.2
|
1.0
|
CAK
|
B:3L7301
|
4.9
|
39.2
|
0.6
|
PBA
|
B:3L7301
|
5.0
|
62.5
|
0.3
|
CAM
|
B:3L7301
|
5.0
|
38.9
|
0.3
|
|
Magnesium binding site 5 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 5 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg302
b:27.6
occ:1.00
|
O
|
C:HOH450
|
1.8
|
57.3
|
1.0
|
OE1
|
C:GLU133
|
2.2
|
39.3
|
1.0
|
O
|
C:HOH448
|
2.2
|
43.6
|
1.0
|
OD1
|
C:ASP134
|
2.3
|
33.7
|
1.0
|
O
|
C:HOH405
|
2.3
|
32.1
|
1.0
|
O
|
C:HOH411
|
2.5
|
35.1
|
1.0
|
O
|
C:HOH451
|
2.6
|
38.6
|
1.0
|
CD
|
C:GLU133
|
2.8
|
43.9
|
1.0
|
OE2
|
C:GLU133
|
3.1
|
43.3
|
1.0
|
CG
|
C:ASP134
|
3.3
|
34.9
|
1.0
|
OD2
|
C:ASP134
|
3.8
|
39.8
|
1.0
|
CG
|
C:GLU133
|
3.8
|
41.2
|
1.0
|
OAD
|
C:3L7301
|
4.1
|
32.8
|
0.8
|
N
|
C:ASP134
|
4.2
|
29.1
|
1.0
|
O
|
C:HOH449
|
4.2
|
58.6
|
1.0
|
CAK
|
C:3L7301
|
4.3
|
53.5
|
0.8
|
O
|
C:ILE135
|
4.4
|
32.1
|
1.0
|
O
|
C:HOH407
|
4.5
|
38.6
|
1.0
|
N
|
C:ILE135
|
4.5
|
33.3
|
1.0
|
CG1
|
C:VAL66
|
4.5
|
34.5
|
1.0
|
CB
|
C:ASP134
|
4.6
|
32.7
|
1.0
|
NAY
|
C:3L7301
|
4.6
|
38.5
|
0.8
|
CG2
|
C:ILE135
|
4.7
|
40.3
|
1.0
|
O
|
C:VAL66
|
4.8
|
28.4
|
1.0
|
CA
|
C:ASP134
|
4.8
|
30.2
|
1.0
|
CAJ
|
C:3L7301
|
4.8
|
46.2
|
0.8
|
CB
|
C:GLU133
|
5.0
|
30.9
|
1.0
|
CB
|
C:VAL66
|
5.0
|
31.6
|
1.0
|
|
Magnesium binding site 6 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 6 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg303
b:41.7
occ:1.00
|
O
|
C:HOH452
|
2.1
|
60.9
|
1.0
|
OD1
|
C:ASP193
|
2.2
|
33.1
|
1.0
|
O
|
C:HOH453
|
2.2
|
81.3
|
1.0
|
O
|
C:HOH421
|
2.3
|
38.3
|
1.0
|
O
|
C:HOH412
|
2.5
|
41.3
|
1.0
|
OAB
|
C:3L7301
|
2.5
|
45.5
|
0.8
|
O
|
C:HOH438
|
2.7
|
57.4
|
1.0
|
CG
|
C:ASP193
|
3.1
|
33.4
|
1.0
|
OD2
|
C:ASP193
|
3.3
|
32.0
|
1.0
|
PBA
|
C:3L7301
|
3.8
|
43.0
|
0.8
|
CAK
|
C:3L7301
|
4.2
|
53.5
|
0.8
|
NH2
|
C:ARG199
|
4.2
|
35.5
|
1.0
|
CAP
|
C:3L7301
|
4.3
|
51.5
|
0.8
|
O
|
C:HOH436
|
4.3
|
47.4
|
1.0
|
O
|
C:HOH415
|
4.3
|
46.8
|
1.0
|
O
|
C:ASP193
|
4.3
|
32.8
|
1.0
|
O
|
C:HOH451
|
4.4
|
38.6
|
1.0
|
OAD
|
C:3L7301
|
4.5
|
32.8
|
0.8
|
CB
|
C:ASP193
|
4.5
|
30.6
|
1.0
|
NH1
|
C:ARG199
|
4.7
|
36.2
|
1.0
|
N3
|
C:3L7301
|
4.7
|
30.8
|
0.8
|
N
|
C:ASP193
|
4.8
|
29.5
|
1.0
|
C
|
C:ASP193
|
4.9
|
32.5
|
1.0
|
CZ
|
C:ARG199
|
4.9
|
33.3
|
1.0
|
OAU
|
C:3L7301
|
4.9
|
52.3
|
0.8
|
OAE
|
C:3L7301
|
5.0
|
39.6
|
0.8
|
CA
|
C:ASP193
|
5.0
|
30.2
|
1.0
|
|
Magnesium binding site 7 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 7 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg302
b:26.2
occ:1.00
|
O
|
D:HOH447
|
1.9
|
49.3
|
1.0
|
O
|
D:HOH445
|
2.1
|
36.6
|
1.0
|
OE1
|
D:GLU133
|
2.1
|
29.4
|
1.0
|
O
|
D:HOH410
|
2.3
|
43.0
|
1.0
|
O
|
D:HOH401
|
2.3
|
37.8
|
1.0
|
OD1
|
D:ASP134
|
2.4
|
29.1
|
1.0
|
CD
|
D:GLU133
|
2.8
|
31.3
|
1.0
|
OE2
|
D:GLU133
|
3.1
|
32.7
|
1.0
|
CG
|
D:ASP134
|
3.4
|
30.6
|
1.0
|
OD2
|
D:ASP134
|
3.8
|
33.5
|
1.0
|
CG
|
D:GLU133
|
3.9
|
34.5
|
1.0
|
CAK
|
D:3L7301
|
4.2
|
76.5
|
1.0
|
CG1
|
D:VAL66
|
4.2
|
31.1
|
1.0
|
OAB
|
D:3L7301
|
4.3
|
79.3
|
1.0
|
N
|
D:ASP134
|
4.3
|
28.1
|
1.0
|
CAP
|
D:3L7301
|
4.5
|
78.1
|
1.0
|
O
|
D:ILE135
|
4.5
|
30.0
|
1.0
|
O
|
D:HOH421
|
4.5
|
38.1
|
1.0
|
N
|
D:ILE135
|
4.6
|
28.8
|
1.0
|
CB
|
D:ASP134
|
4.7
|
25.9
|
1.0
|
NAY
|
D:3L7301
|
4.7
|
54.5
|
1.0
|
O
|
D:VAL66
|
4.7
|
22.3
|
1.0
|
CAJ
|
D:3L7301
|
4.7
|
68.3
|
1.0
|
CB
|
D:VAL66
|
4.9
|
26.2
|
1.0
|
CA
|
D:ASP134
|
4.9
|
21.9
|
1.0
|
OAU
|
D:3L7301
|
5.0
|
74.4
|
1.0
|
|
Magnesium binding site 8 out
of 8 in 4rao
Go back to
Magnesium Binding Sites List in 4rao
Magnesium binding site 8 out
of 8 in the Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 8 of Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6- Oxopurine Phosphoribosyltransferases and Their Pro-Drugs As Antimalarial Agents within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg303
b:45.2
occ:1.00
|
OD1
|
D:ASP193
|
2.2
|
33.9
|
1.0
|
O
|
D:HOH425
|
2.3
|
42.9
|
1.0
|
O
|
D:HOH446
|
2.3
|
53.5
|
1.0
|
OAE
|
D:3L7301
|
2.7
|
0.7
|
1.0
|
CG
|
D:ASP193
|
3.0
|
33.1
|
1.0
|
OD2
|
D:ASP193
|
3.2
|
35.7
|
1.0
|
CAP
|
D:3L7301
|
3.3
|
78.1
|
1.0
|
PBA
|
D:3L7301
|
3.6
|
81.7
|
1.0
|
NH2
|
D:ARG199
|
4.3
|
31.1
|
1.0
|
O
|
D:ASP193
|
4.3
|
34.1
|
1.0
|
CB
|
D:ASP193
|
4.4
|
31.0
|
1.0
|
O
|
D:HOH431
|
4.5
|
47.4
|
1.0
|
OAB
|
D:3L7301
|
4.6
|
79.3
|
1.0
|
CAK
|
D:3L7301
|
4.7
|
76.5
|
1.0
|
N3
|
D:3L7301
|
4.7
|
39.7
|
1.0
|
OAD
|
D:3L7301
|
4.7
|
80.1
|
1.0
|
C
|
D:ASP193
|
4.8
|
33.3
|
1.0
|
N
|
D:ASP193
|
4.8
|
28.7
|
1.0
|
NH1
|
D:ARG199
|
4.8
|
30.3
|
1.0
|
O
|
D:HOH401
|
4.9
|
37.8
|
1.0
|
CA
|
D:ASP193
|
4.9
|
30.3
|
1.0
|
CZ
|
D:ARG199
|
5.0
|
31.8
|
1.0
|
|
Reference:
D.T.Keough,
D.Hockova,
Z.Janeba,
T.H.Wang,
L.Naesens,
M.D.Edstein,
M.Chavchich,
L.W.Guddat.
Aza-Acyclic Nucleoside Phosphonates Containing A Second Phosphonate Group As Inhibitors of the Human, Plasmodium Falciparum and Vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents. J.Med.Chem. V. 58 827 2015.
ISSN: ISSN 0022-2623
PubMed: 25494538
DOI: 10.1021/JM501416T
Page generated: Tue Aug 20 02:58:39 2024
|